Sanjay Murdeshwar

Positive results from Novartis five-year VERIFY study in type 2 diabetes demonstrate long-term clinical benefits of early combination treatment with vildagliptin and metformin

Early combination treatment strategy with vildagliptin and metformin was superior to standard of care in newly diagnosed type 2 diabetes…

5 years ago

Novartis continues to build healthcare talent ecosystem; announces BioCamp 2019

BioCamp engages students around scientific advances to address unmet medical needs and entrepreneurial opportunitiesĀ  Offers ~50 post-graduate students insights in…

5 years ago

Novartis India Limited reconstitutes Board; appoints Sanjay Murdeshwar as Vice Chairman & Managing Director

Mumbai, June 15, 2019: At a meeting held in Mumbai today, the Board of Directors of Novartis India Limited announced…

6 years ago